Has the clock stopped on Swiss US trade?

Switzerland faces high tariffs on exports to the US, impacting its competitive economy and potentially leading to job losses. The Swiss government's efforts to renegotiate with the US have been unsuccessful, with industries like pharmaceuticals and medical technology feeling the brunt of the tariffs. Companies like MPS in Biel illustrate the intricate production processes that may not easily shift to the US. The situation highlights concerns about rising costs for US patients and taxpayers, and the potential halt of Swiss exports to the US, further complicating trade relations.